National estimates of the prevalence of Alzheimer's disease in the United States, Alzheimers Dement, vol.7, pp.61-73, 2011. ,
Alzheimer's disease drug development pipeline, Alzheimers Dement, vol.3, pp.367-84, 2017. ,
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.270-279, 2011. ,
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, vol.6, pp.734-780, 2007. ,
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, vol.13, pp.614-643, 2014. ,
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol, vol.66, pp.382-391, 2009. ,
A phase 3 Trial of Solanezumab in Mild Dementia due to Alzheimer's Disease, EXPEDITION, vol.3, 2016. ,
Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer's Disease to Stop for Lack of, 2017. ,
The antibody aducanumab reduces A? plaques in Alzheimer's disease, Nature, vol.537, pp.50-56, 2016. ,
Eisai and Biogen announce positive topline results of the final analysis for BAN2401 at 18 months. enews201858, 2018. ,
French Alzheimer plan: description of the national Alzheimer information system, J Alzheimers Dis, vol.29, pp.891-902, 2008. ,
New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting, Am J Geriatr Psychiatry, vol.23, pp.768-79, 2015. ,
Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, pp.189-98, 1975. ,
, WHO. International Classification of Diseases
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.263-272, 2011. ,
Mild cognitive impairment as a diagnostic entity, J Intern Med, vol.256, pp.183-94, 2004. ,
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, J Neuropathol Exp Neurol, vol.71, pp.266-73, 2005. ,
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease, N Engl J Med, vol.370, pp.322-355, 2014. ,
Mild cognitive impairment due to Alzheimer disease in the community, Ann Neurol, vol.74, pp.199-208, 2013. ,
Screening for dementia by memory testing, Neurology, vol.38, pp.900-903, 1988. ,
Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial, J Alzheimers Dis, vol.48, pp.793-804, 2015. ,
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study, Neurology, vol.69, pp.1859-67, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00169640
Validity of the free and cued selective reminding test in predicting dementia: the 3C study, Neurology, vol.74, pp.1760-1767, 2010. ,
Free and cued selective reminding distinguishes Alzheimer's disease from vascular dementia, J Am Geriatr Soc, vol.56, pp.944-950, 2008. ,
Free and cued selective reminding identifies very mild dementia in primary care, Alzheimer Dis Assoc Disord, vol.24, pp.1-90, 2010. ,
Alzheimer profile": Easily said. but what does it mean?, Alzheimers Dement, 2014. ,
Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab, Arch Neurol, vol.69, pp.198-207, 2012. ,
Optimizing patient care and research: the Amsterdam Dementia Cohort, J Alzheimers Dis, vol.41, pp.313-340, 2014. ,
Incidence and mortality of Alzheimer's disease or dementia using an illness-death model, Stat Med, vol.23, pp.199-210, 2004. ,
Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders ,
, Presse Med, vol.47, pp.75-83, 2018.
,
, C R Biol, vol.325, pp.665-72, 2002.
Alzheimer enjeux scientifiques, médicaux et sociétaux, Inserm publication, pp.431-476, 2007. ,
Diagnosing cognitive impairment and dementia in primary health care -a more active approach is needed, Age Ageing, vol.32, pp.606-618, 2003. ,
Detection of dementia in primary care: the Linköping study, Dement Geriatr Cogn Disord, vol.11, pp.223-232, 2000. ,
Do general practitioners miss dementia in elderly patients?, BMJ, vol.297, pp.1107-1117, 1988. ,
Screening for cognitive impairment in the elderly, Can Fam Physician, vol.43, pp.1763-1771, 1997. ,
Documentation and evaluation of cognitive impairment in elderly primary care patients, Ann Intern Med, vol.122, pp.422-431, 1995. ,
Implications of the Facing Dementia Survey for the general population, patients and caregivers across Europe, Int J Clin Pract Suppl, vol.146, pp.17-24, 2005. ,
Implications of the Facing Dementia Survey for health care professionals across Europe, Int J Clin Pract, vol.59, pp.27-31, 2005. ,
The French CONSTANCES population-based cohort: design, inclusion and follow-up, Eur J Epidemiol, vol.30, pp.1317-1345, 2015. ,
The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database, PLoS One, vol.9, p.103630, 2014. ,
Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample, J Affect Disord, vol.146, pp.383-392, 2013. ,
Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application, Am Soc Clin Oncol Educ Book, vol.35, pp.83-90, 2016. ,
Who needs cerebrospinal biomarkers? A national survey in clinical practice, J Alzheimers Dis, vol.40, pp.857-61, 2014. ,
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting, Alzheimers Dement, vol.9, pp.406-419, 2013. ,
Impact of cerebrospinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study, J Neurol, vol.261, pp.144-51, 2014. ,
Toward a biological definition of Alzheimer's disease, Alzheimers Dement, vol.14, pp.535-62, 2018. ,
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers, Neurology, vol.87, pp.539-586, 2016. ,
Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart, Lancet, vol.382, pp.1507-1520, 2013. ,
A Comparison of the Prevalence of Dementia in the United States in, JAMA internal medicine, 2000. ,
A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II, Lancet, vol.382, pp.1405-1417, 2013. ,
Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America, J Alzheimers Dis, vol.43, pp.1271-84, 2015. ,
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia, JAMA, vol.321, pp.1286-94, 2019. ,
High performance plasma amyloid-? biomarkers for Alzheimer's disease, Nature, vol.554, pp.249-54, 2018. ,